(Q36273001)

13 August 2017

Molecular biology of medulloblastoma: will it ever make a difference to clinical management? (English)

1 reference

13 August 2017

0 references

0 references

Richard J Gilbertson

1

1 reference

PubMed ID

16195803

13 August 2017

Amar Gajjar

series ordinal

2

1 reference

13 August 2017

1 December 2005

1 reference

Journal of Neuro-Oncology

13 August 2017

1 reference

13 August 2017

75

1 reference

13 August 2017

3

1 reference

13 August 2017

273-278

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-005-6750-z

13 August 2017

0 references

cites work

p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-6750-Z

APC mutations in sporadic medulloblastomas

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-6750-Z

Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-6750-Z

High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

21 January 2018

1 reference

12 December 2020

Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.

1 reference

12 December 2020

TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors

1 reference

12 December 2020

Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours

1 reference

12 December 2020

Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling

1 reference

12 December 2020

Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.

1 reference

12 December 2020

Oncogene amplification in pediatric brain tumors.

1 reference

12 December 2020

Medical applications of microarray technologies: a regulatory science perspective

1 reference

12 December 2020

The Hallmarks of Cancer

1 reference

12 December 2020

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

1 reference

12 December 2020

C-MYC expression in medulloblastoma and its prognostic value.

1 reference

12 December 2020

Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma

1 reference

12 December 2020

Molecular profiling of human cancer

1 reference

12 December 2020

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

12 December 2020

Sporadic medulloblastomas contain PTCH mutations.

1 reference

12 December 2020

Enhanced expression of the N-myc gene in Wilms' tumors

1 reference

12 December 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

Infrequent p53 gene mutations in medulloblastomas.

1 reference

12 December 2020

Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease

1 reference

12 December 2020

MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.

1 reference

12 December 2020

The Sequence of the Human Genome

1 reference

12 December 2020

Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study

1 reference

12 December 2020

What's new in neuro-oncology? Recent advances in medulloblastoma

1 reference

12 December 2020

Medulloblastoma: signalling a change in treatment

1 reference

12 December 2020

Prediction of central nervous system embryonal tumour outcome based on gene expression

1 reference

12 December 2020

PDGFRB is overexpressed in metastatic medulloblastoma

1 reference

12 December 2020

Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study

1 reference

12 December 2020

Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma.

1 reference

12 December 2020

N-myc and c-myc oncogenes amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with c-myc amplification.

1 reference

12 December 2020

DNA microarrays in clinical oncology

1 reference

12 December 2020

Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development.

1 reference

12 December 2020

Mutations in SUFU predispose to medulloblastoma

1 reference

12 December 2020

The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system

1 reference

12 December 2020

Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma

1 reference

12 December 2020

10.1007/S11060-005-6750-Z

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16195803